中国僵尸片,亚洲欧美国产另类视频,亚洲精品无码人妻无码,亚洲有码转帖,亚洲欧美精品伊人久久,97精品依人久久久

該職位已失效,看看其他機(jī)會(huì)吧

DMPK Research Investigator (Beijing or Shanghai)) (MJ018327)

1.6-2.2萬(wàn)
  • 上海浦東新區(qū)
  • 3-5年
  • 碩士
  • 全職
  • 招1人

職位描述

新藥
Responsibilities:
  • Possess a solid understanding of DMPK principles to guide CROs in completing preclinical DMPK packages that support clinical research or regulatory submissions.
  • Collaborate with colleagues from other R&D departments (Chemistry, Toxicology, Pharmacology, Biomarkers, Clinical, etc.) and global regulatory teams to provide DMPK research support during drug development stages.
  • Assist in the preparation and writing of various DMPK submission documents.
  • Represent the team at internal governance meetings, advise on optimal approaches for regulatory reviews and program progression, and ensure compliance with guidelines from all health authorities concerning Development DMPK matters.
Requirements:
  • Master's or Ph.D. degree in Pharmacokinetics or a related field; at least one year of work experience, with preference given to candidates with DMPK or large molecule PK submission experience.
  • Ability to collaborate cross-functionally with colleagues and work independently.
  • Strong scientific insight and problem-solving skills, meticulous attention to detail, and the ability to learn and adapt quickly.
  • Excellent communication and writing skills in both Chinese and English.
  • Proficiency in using GastroPlus, and familiarity with Excel, Word, PowerPoint, and other office software.
百濟(jì)神州全球勝任力 當(dāng)我們通過(guò)以下十二項(xiàng)全球勝任力,展現(xiàn)出 "患者為先"、"無(wú)界協(xié)作"、"銳意創(chuàng)新 "和 "追求卓越 "的價(jià)值觀時(shí),我們就能幫助全世界更多患者獲得更多負(fù)擔(dān)得起的藥品。 ●團(tuán)隊(duì)協(xié)作 ●提供并征求坦誠(chéng)及可行的反饋 ●自我認(rèn)知 ●兼容并蓄 ●積極主動(dòng) ●開(kāi)拓精神 ●持續(xù)學(xué)習(xí) ●擁抱變化 ●結(jié)果導(dǎo)向 ●分析性思維/數(shù)據(jù)分析 ●卓越財(cái)務(wù) ●清晰溝通 BeiGene Global Competencies When we exhibit our values of Patients First, Collaborative Spirit, Bold Ingenuity and Driving Excellence, through our twelve global competencies below, we help get more affordable medicines to more patients around the world. ●Fosters Teamwork ●Provides and Solicits Honest and Actionable Feedback ●Self-Awareness ●Acts Inclusively ●Demonstrates Initiative ●Entrepreneurial Mindset ●Continuous Learning ●Embraces Change ●Results-Oriented ●Analytical Thinking/Data Analysis ●Financial Excellence ●Communicates with Clarity 求職者隱私申明: 百濟(jì)神州致力于尊重和保護(hù)您的個(gè)人信息權(quán)利,并承諾依據(jù)合法、正當(dāng)、必要和誠(chéng)信的原則處理您的個(gè)人信息(包括個(gè)人敏感信息 )。 由于百濟(jì)神州在全球范圍內(nèi)開(kāi)展業(yè)務(wù),我們可能需要基于人力資源管理等合理業(yè)務(wù)目的而將您的個(gè)人信息發(fā)送和/或存儲(chǔ)在位于您所在國(guó)家以外其他國(guó)家(例如:美國(guó))的服務(wù)器和數(shù)據(jù)庫(kù)中,詳情參見(jiàn)百濟(jì)神州《求職者隱私政策》(百濟(jì)神州官網(wǎng) - 隱私政策 - 求職者隱私政策)。 如您主動(dòng)向我們提供您的簡(jiǎn)歷信息或其他個(gè)人信息,則視為您已經(jīng)充分理解并確認(rèn)接受百濟(jì)神州《求職者隱私政策》內(nèi)容。如您對(duì)此有任何疑問(wèn)的,請(qǐng)勿提交簡(jiǎn)歷信息或其他個(gè)人信息。 BeiGene is committed to respect and protect your personal information rights, and will process your personal information, including your sensitive personal information, based on the principles of legality, legitimacy, necessity, and integrity. Due to the reasonable business need for human resource management as a result of BeiGene’s global operation, your personal information may be transferred and/ or stored in a server/database located in a third country (e.g., the United States) other than your own country. For further details, please refer to BeiGene Job Applicant Privacy Policy (BeiGene official website - Privacy Policy - Job Applicant Privacy Policy). If you voluntarily provide your resume or other personal information to us, it is deemed as you have thoroughly acknowledged and accepted BeiGene Job Applicant Privacy Policy. If you have any concern, please DO NOT submit your resume or any other personal information.
查看全部

工作地點(diǎn)

浦東新區(qū)百濟(jì)神州(上海)醫(yī)藥研發(fā)有限公司

職位發(fā)布者

張婧媛/百濟(jì)神州研發(fā)招聘recruiter

昨日活躍
立即溝通
公司Logo百濟(jì)神州北京
About BeiGene BeiGene is a publically traded(BGNE, NASDAQ), globally focused biopharmaceutical company dedicated to becoming a leader in the discovery and development of innovative, molecularly targeted and immuno-oncology drugs for the treatment of cancer. Our cancer biology platform addresses the importance of tumor-immune system interactions and the value of primary tumor biopsies in developing new cancer models. We have a global team of over 200 individuals, including over 150 scientists and clinicians, and a world-renowned scientific advisory board, with deep scientific talent, extensive pharmaceutical experience, and a commitment to improving the lives of cancer patients around the world. Our clinical pipeline is comprised of novel oral small molecules and monoclonal antibodies(mAb) for cancer, including an anti-PD-1 monoclonal antibody, a best-in-class BTK inhibitor, a RAF dimer inhibitor, a best-in-class PARP inhibitor, and a variety of combination clinical studies. In addition, our robust preclinical programs are expected to generate more small molecule and mAb drugs for clinical development in coming years. For more information, please visit our website at www.beigene.com.
公司主頁(yè)